AACR Members: Voting is open through February 28 for AACR President, Board of Directors, and Nominating Committee.
Select "Patients / Caregivers / Public" or "Researchers / Professionals" to filter your results. To further refine your search, toggle appropriate sections on or off.
Home > Patients, Caregivers, and Advocates > About Cancer > Cancer Types > Acute Lymphoblastic Leukemia > Adult Acute Lymphoblastic Leukemia Treatment (PDQ®)
Challenging the Odds of Recurrent Leukemia
FDA Rounded out 2018 With Three Oncology Approvals
Taking Hope from Molecularly Targeted Therapy